SCHEMBL8310353

SCHEMBL8310353

CC(/C=C/C(=O)O)=C\C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
TSHR P16473 3/20 0.54
HSD17B10 Q99714 3/20 0.54
TDP1 Q9NUW8 3/20 0.54
ALOX15 P16050 2/20 0.54
RECQL P46063 2/20 0.54
TP53 P04637 1/20 0.53
EGLN1 Q9GZT9 1/20 0.53
EGLN3 Q9H6Z9 1/20 0.53
MAPT P10636 4/20 0.44
KDM4E B2RXH2 4/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
HCAR2 Q8TDS4 3/20 0.42
POLB P06746 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.39
RXRA P19793 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2934603 1.00 ALDH1A1 (0.54) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL2934605 1.00 ALDH1A1 (0.54) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL13176444 0.86 ALDH1A1 (0.52) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL17276909 0.82
SCHEMBL17276913 0.82
SCHEMBL14965630 0.81 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL14965632 0.81 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL14952903 0.81 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL14952904 0.81 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10TDP1ALOX15
SCHEMBL12784591 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459289-B2 Conversion of dicarboxylic acids to monomers and plasticizers ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2022-10-04 US disclosed
US-11459289-B2 Conversion of dicarboxylic acids to monomers and plasticizers ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2022-10-04 US disclosed
US-20200377443-A1 CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERS Alliance for Energy Innovation, LLC 2020-12-03 US disclosed
US-20200377443-A1 CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERS Alliance for Energy Innovation, LLC 2020-12-03 US disclosed
US-10793506-B2 Conversion of dicarboxylic acids to monomers and plasticizers ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2020-10-06 US disclosed
US-10793506-B2 Conversion of dicarboxylic acids to monomers and plasticizers ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2020-10-06 US disclosed
US-20200255368-A1 CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERS Alliance for Energy Innovation, LLC 2020-08-13 US disclosed
US-20200255368-A1 CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERS Alliance for Energy Innovation, LLC 2020-08-13 US disclosed
EP-0800504-B1 TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE LIGAND PHARM INC (US) 1999-12-01 EP disclosed
EP-0933351-A1 Tricyclic retinoids, methods for their production and use LIGAND PHARMACEUTICALS INCORPORATED (US) 1999-08-04 EP disclosed
EP-0933350-A1 Tricyclic retinoids, methods for their production and use LIGAND PHARMACEUTICALS INCORPORATED (US) 1999-08-04 EP disclosed
EP-0800504-A1 TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 EP disclosed
WO-1996020914-A1 TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-07-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377443-A1 CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERS TRRAP, HCAR2, SCD ALDH1A1 1201/4885TSHR 3357/4885HSD17B10 141/4885
US-11459289-B2 Conversion of dicarboxylic acids to monomers and plasticizers TRRAP, HCAR2, SCD ALDH1A1 1201/4885TSHR 3357/4885HSD17B10 141/4885
US-20200255368-A1 CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERS TRRAP, HCAR2, SCD ALDH1A1 1201/4885TSHR 3357/4885HSD17B10 141/4885
US-10793506-B2 Conversion of dicarboxylic acids to monomers and plasticizers TRRAP, HCAR2, SCD ALDH1A1 1201/4885TSHR 3357/4885HSD17B10 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.